BENZOXABOROLE COMPOUNDS SUBSTITUTED AT POSITION 4 AND ASSOCIATED USES
Patent Information
- Application Number
- MA41494
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2016-02-12
- Filing Date
- 2016-02-11
- Publication Date
- 2017-12-19
- Estimated Expiration
- Not applicable · inactive patent
AI Technical Summary
Current tuberculosis treatments face challenges such as long duration, poor patient compliance, emergence of multi-drug resistant strains, and adverse interactions, necessitating the development of shorter, more effective regimens that can be taken less frequently and are effective against Mycobacterium tuberculosis, including strains resistant to standard drugs.
Substituted benzoxaboroles with specific structural features, such as those described in Formula III, exhibit selective inhibition of Mycobacterium tuberculosis replication with sub-micromolar MIC values, potentially used in combination with existing anti-tubercular agents to enhance efficacy and address resistance issues.
These compounds demonstrate improved selectivity and efficacy against Mycobacterium tuberculosis, offering a potential solution for shorter treatment durations and reduced resistance development, while being effective against both drug-sensitive and resistant strains.